[The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects; D010743:Phospholipids / Q000008:administration & dosage*; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D010743:Phospholipids; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin
Die Hepatotoxizität von Rifampicin und ihre Beeinflussung durch "essentielle" Cholinphospholipide.